An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann (and) Robert H. Lurie Children's Hospital of Chicago, found that a regimen was safe and effective in 6-11-year-olds.
from Medindia Health News https://ift.tt/3qXcLf7
No comments:
Post a Comment